Risperidone Reactions 1680, p299 - 2 Dec 2017 Idiopathic granulomatous mastitis with hyperprolactinaemia: case report A 55-year-old woman developed idiopathic granulomatous mastitis (IGM) with hyperprolactinaemia following the therapy with risperidone. The woman presented with a one month history of swelling and pain in her left breast. Subsequent core biopsies of the lesions demonstrated focal inflammation. Her medical history included depression and schizoaffective disorder, for which she was successfully treated with risperidone for a number of years [route and dosage not stated]. Examination showed a large mass with erythema and suppuration over the lateral aspect of her left breast. She had long standing bilateral nipple inversion. Based on the physical exam and biopsy, a presumptive diagnosis of infective duct ectasia was made. The woman received treatment with amoxicillin and clavulanic acid. However, after two weeks of the treatment, there was no improvement. The overlying skin had broken down and was suppurating. A further biopsy was conducted that confirmed the manifestation of the suspected IGM. Owing to the probability of the development of hyperprolactinaemia due to risperidone use, a serum prolactin level investigation was performed, which showed increased levels. Hence, she was diagnosed with risperidone induced hyperprolactinaemia, with associated IGM [duration of therapy to reaction onsets not stated]. She then received bromocriptine treatment. Within a month of the treatment, her condition completely resolved. At a follow up after 1.5 years, there was no sign of recurrence of events. Author comment: "We present a 55 year old female with IGM associated with risperidone induced hyperprolactinaemia." Li J, et al. Idiopathic granulomatous mastitis associated with hyperprolactinemia: A nonoperative approach. Breast Journal 23: 742-744, No. 6, Nov 2017 - Australia 803284714 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals


Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site


You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial